Jung-Im Lee

Title: Innovator Jung-Im Lee: Advancing Photodynamic Therapy Techniques

Introduction: Jung-Im Lee is an accomplished inventor based in Gyeonggi-do, South Korea. With a focus on enhancing photodynamic therapy and diagnosis, she has made significant contributions to the field of cancer treatment through her innovative research and patented technologies.

Latest Patents: Jung-Im Lee holds a patent for a "Photosensitizer-metal nanoparticle charge complex and composition containing the complex for photodynamic therapy or diagnosis." This invention comprises a complex that includes a metal nanoparticle and a photosensitizer, which is charged with a first charge, along with a linker that binds to the metal nanoparticle and carries a second charge of opposite polarity. This innovative approach allows the complex to maintain its form during circulation within the bloodstream, effectively reducing the duration of side effects associated with photosensitivity. This complex is designed to selectively target tumor tissue while limiting penetration in normal tissue, thus enabling targeted destruction of cancerous cells. Additionally, the selective fluorescence within tumor tissue significantly enhances the accuracy of tumor diagnosis.

Career Highlights: Jung-Im Lee is currently affiliated with the National Cancer Center, where her work focuses on pioneering advanced treatments for cancer using her patented technologies. With a deep commitment to research, she aims to contribute substantially to the field of oncology and improve patient outcomes through innovation.

Collaborations: Jung-Im Lee has collaborated with esteemed colleagues such as Yong-Doo Choi and Bo-Seung Jang. These collaborations emphasize the importance of teamwork in advancing medical research and developing cutting-edge solutions in the fight against cancer.

Conclusion: As a dedicated inventor and researcher, Jung-Im Lee’s contributions are poised to make a significant impact in the realm of photodynamic therapy. Her innovative patent not only addresses current challenges in cancer treatment but also paves the way for more targeted and effective therapeutic strategies. Through her ongoing work at the National Cancer Center and collaborations with fellow researchers, she is set to continue leading advancements in medical technology.